PAYER POLICY CHANGES

J3401 Insurance Policy Changes

HCPCS J3401 is officially defined as "Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml." HCPCS J3401 is referenced in 4 tracked payer policy changes from Harvard Pilgrim Health Care, Aetna, and 2 other payers. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J3401 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Watch J3401

Get one email when a payer policy names J3401, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

See every payer rule for J3401

Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for J3401 in one place.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.